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Resumo
A presença de tecido mamário ectópico é 
encontrada em menos de 6% da população e é 
sede de patologia benigna e maligna tal como o 
tecido mamário normal. A axila é a topografia 
mais frequente.  Os autores descrevem um 
caso de uma paciente de 43 anos que se 
apresentou com uma massa palpável na linha 
axilar anterior, indolor e presente há 3 anos. 
Nos estudos de imagem correspondia a uma 
lesão nodular subcutânea hipoecogénica, que 
mostrou crescimento ao longo do tempo. Foi 
efectuada biópsia que confirmou carcinoma 
lobular invasivo da mama em tecido mamário 
ectópico. O estadiamento locoregional com 
ressonância magnética (RM) não mostrou outras 
alterações. A paciente foi submetida a excisão 
local alargada seguida de radioterapia. Este artigo 
mostra uma apresentação rara de tecido ectópico 
mamário como carcinoma da mama, com enfase 
nas características clinicas e imagiológicas e a 
importância de um diagnóstico atempado para 
implementação de terapêutica apropriada.
Palavras-chave
Cancro de mama; Tecido mamário ectópico; 
tecido mamário acessório.
Abstract
Ectopic breast tissue (EBT) is found in no more 
than 6% of  the population. The axilla is the most 
common location. 
We report a case of  a 43-year-old woman that 
showed a painless small lump on her right 
anterior axillary line adjacent to the axilla, for 
three years. On ultrasound it corresponded to a 
growing unspecific hypochogenic subcutaneous 
nodule. A core biopsy was performed and the 
histologic diagnosis was that of  an invasive 
lobular breast carcinoma in an aberrant EBT. 
A locoregional staging by magnetic resonance 
(MR) was performed showing no other lesions. 
Patient underwent wide local excision of  the 
lesion followed by radiotherapy and hormone 
therapy. This article underlines the possibility 
of  presentation of  EBT as an invasive breast 
carcinoma, emphasizing its clinical and imaging 
features and the importance of  its prompt 
recognition for a timely treatment.
Keywords
Breast cancer; Ectopic breast; Accessory breast 
tissue.
Caso Clínico / Radiological Case Report
Case Presentation
A 43-year-old white female with no relevant family history of  
breast cancer, presented to us with a 3-year history of  a small 
lump on the superior aspect of  the right anterior axillary line. 
The previous medical history was unremarkable. 
In the previous years, there were no significant findings on the 
mammograms and on the breast ultrasound, the palpable lump 
corresponded to a 13 mm subcutaneous nodule, with features 
of  benignity: oval shape and smooth contour, hypoechoic, 
with no acoustic shadow, nor involvement of  the adjacent skin, 
with major axis parallel to the skin surface. The lesion had no 
internal signal on color Doppler ultrasound. This finding was 
already described on previous breast exams for the past three 
years and showed minimal growth.
Investigations
On physical examination, a small fixed and painless palpable 
lump was detected on her right anterior axillary line near the 
axilla (Fig. 1). There were no changes in the adjacent skin 
surface and absence of  nipple or areolar complex. No palpable 
Figure 1 – On examination a small fixed palpable lump was detected on 
the right anterior axillary line near the axilla (arrows). The adjacent skin 
surface had no change. 
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bilateral breast or contralateral axillary lesions where found.
In our breast evaluation, mediolateral oblique mammograms 
showed on the right axilla a discreet focal asymmetric 
density of  isolated fibroglandular tissue containing small 
amounts of  scattered fat tissue, with no connection with 
the remaining anatomic breast, suggestive of  EBT in 
the right axilla (Fig. 2A). There were no other relevant 
mammographic findings.
On breast ultrasound, a lesion was identified showing 
irregular margins, increased size comparing with the 
previous ultrasounds, measuring 15.7 mm of  major axis 
and no cleavage plane with adjacent skin surface. There was 
no posterior acoustic shadowing (Fig. 2B) or internal signal 
on color Doppler ultrasound (Fig. 2C).
Because of  these suspicious findings, an uneventful 
ultrasound guided core biopsy was performed. The 
histologic diagnosis was that of  an invasive lobular breast 
carcinoma in an aberrant EBT.
A magnetic resonance (MR) study was performed as 
locoregional staging, revealing on axial and sagittal T2-
weighted MR images axillary ectopic breast tissue bilaterally, 
and a subcutaneous nodular lesion, with irregular borders 
and intermediate signal intensity, in the right anterior axillary 
line near the axilla, measuring 16.4 mm of  longest axis 
(circle) (Fig. 3A). In the dynamic contrast-enhanced MR 
imaging the lesion demonstrated an early and progressive 
enhancement with an intensity peak after two minutes and 
a time-signal intensity curve not suggestive of  malignancy 
(Fig. 3B, C e D). The lesion didn’t show restricted diffusion. 
No other lesions were detected in both breast and axillary 
lymph nodes had normal size.
Differential Diagnosis
The differential diagnosis of  EBT carcinoma should 
include lipoma, excess axillary fat, fibroadenoma, 
sebaceous cyst, epidermoid cyst, benign lymphadenopathy, 
lymphadenitis, metastatic carcinoma, lymphoma, and 
hidradenitis suppurativa. In the presence of  a pigmented 
axillary lesion, the differential diagnosis includes seborrheic 
keratosis, fibromas, and intradermal nevis.
Treatment
The patient underwent wide local excision with ipsilateral 
sentinel lymph node biopsy that was negative. The surgical 
margins were free. The lesion was staged as a pT1cN0M0.
The patient was submitted to adjuvant radiotherapy and 
hormone therapy.
Outcome and follow-up  
The histopathologic examination of  the specimen revealed 
the diagnosis of  an invasive lobular carcinoma in ectopic 
breast tissue. The immunohistochemical evaluation 
results were positive for estrogen receptor (100%) and for 
progesterone receptor (50%), ERBB2 was negative (2+) 
and Ki67 was <1% in the tumoral cells. The estrogens 
receptors expression in the ectopic breast lobule was 
weaker than in the cancer cells.
The final pathologic diagnosis was of  an invasive lobular 
carcinoma in aberrant ectopic breast tissue in the right 
anterior axillary line adjacent to the axilla.
Figure 2 – (A) Bilateral mediolateral oblique mammogram views showed on the right axilla a discreet focal asymmetric density of  isolated fibroglandular 
tissue containing small amounts of  scattered fat (circle), with no connection with the remaining anatomic breast tissue, suggestive of  ectopic breast 
tissue in the right axilla. (B) On breast ultrasound, an oval palpable hypoechogenic subcutaneous nodule was identified in the right anterior axillary line, 
presenting in the present study an irregular contour, increased size (15.7 mm of  major axis) and no cleavage plane with adjacent skin surface. It showed 
no posterior acoustic shadowing. (C) This lesion had no internal signal on colour Doppler ultrasound.
The patient recovered from surgery and radiotherapy 
without complications and stays asymptomatic in eight 
months of  follow-up.
Discussion
EBT is synonymous of  accessory breast tissue and 
polymastia. Its origin is related to the incomplete regression 
of  the mammary ridges in embryogenesis process leading 
to the development of  more than two breasts in one 
person.1,2,4-6 It appears in the milk line, from the axilla 
(60-70%) to the vulva, which are the most common 
localizations of  EBT.1-5
Up to 6% of  the population presents EBT.1-4 This finding 
is more frequent in women than in men, and as a higher 
prevalence in Asian population.6
EBT has two forms of  presentation a supernumerary 
and an aberrant form. Supernumerary EBT vary in its 
components, and can have a nipple, areola, or both, 
associated to persistent or atrophic glandular tissue. It 
is histologically characterized by organized duct system 
communicating with the overlying skin. It is affected 
by the cycle hormonal changes.1,2,6,7 Aberrant breast 
tissue (ABT) is defined on histology as isolated breast 
tissue without organized secretory system and with no 
relationship with the adjacent skin. ABT most frequent 
anatomical presentation is axillary, however it may appear 
in parasternal, subclavicular, submammary or vulvar 
locations. ABT is also influenced by hormonal variations. 
The true prevalence of  ABT is unknown because is not 
visible or palpable in normal conditions. It is only detected 
when associated with clinically significant pathology.1,3,4,7
Benign and malignant pathologies of  normally located 
breast tissue can occur in EBT.2,3
EBT carcinoma corresponds to 0.3-0.6% of  all breast 
cancers.2,4,8 Like on anatomic breast tissue, invasive ductal 
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Figure 3 – Axial T2-weighted MR image (A) reveals a subcutaneous nodular lesion in axillary ectopic breast tissue in the right anterior axillary line (circle), 
with irregular borders, and intermediate to low signal intensity, measuring 16.4 mm of  long axis. On axial (B, C) dynamic contrast-enhanced MR image 
this lesion (circle) shows early and progressive enhancement with an intensity peak after two minutes and a time-signal intensity curve with mild late 
washout (D).
carcinoma (79%) is the most common histological type, 
followed by medullary carcinoma, and less than 10% of  
these are lobular carcinomas.1-5
The axilla is the most common location of  ABT carcinoma.7 
The correct preoperative diagnosis of  ABT carcinomas is 
rarely achieved, because they have no associated nipple or 
areola, and are frequently mistaken with a subcutaneous 
nodule.5
The guidelines for anatomic breast cancer diagnosis 
showed be applied in EBT carcinoma, including diagnosis 
(core-needle biopsy), staging (clinical examination, 
mammography, ultrasonography, MR imaging), and 
treatment (surgery and adjuvant therapy).
EBT carcinomas most commonly present as a palpable 
lump on physical examination. Edema and tenderness can 
also be associated.5
Mammographic findings are nonspecific in most the 
cases, and best visualized on the mediolateral oblique 
or exaggerated craniocaudal views. Frequently, EBT 
appears as an axillary discrete focal asymmetric density 
of  fibroglandular tissue mixed with fat tissue, showing 
no communication with the anatomic breast. When EBT 
carcinoma is present these features can become more 
dense, well circumscribed, assuming a nodular shape, and 
microcalcifications can also be found.6
On ultrasound EBT has the same appearance as normal 
glandular tissue. A poorly defined hypochogenic lesion, or 
with irregular margins and acoustic shadowing, without 
associated inflammation signs should be suspicious.5,6
To evaluate neoplasm locoregional extension a MRI should 
also be performed assessing both breasts and axilla.5,8,9
The evaluation of  the contralateral axilla and breast is 
important, since 13% of  anatomic breast cancers are 
bilateral.3,9
On histopathological analysis EBT carcinoma can be 
difficult to differentiate from axillary metastasis of  another 
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primary origin carcinoma. The detection of  estrogen and 
progesterone receptors and the visualization of  normal 
ABT adjacent to the tumor are helpful factors in the 
accurate diagnosis of  an EBT carcinoma.4,6,8
Anatomic breast carcinoma treatment approach should 
be the same for EBT carcinoma. Metastatic disease 
should be excluded. Surgical approach usually includes 
a wide local excision with sentinel lymph node biopsy. 
Adjuvant treatment for EBT carcinoma should follow the 
recommendations for normal breast cancers, including 
adjuvant radiotherapy to the EBT carcinoma site and to 
the regional lymph nodes.4-6,10
There is no proven benefit of  radical or modified ipsilateral 
mastectomy or homolateral anatomic breast irradiation over 
local excision. However, in cases of  undetermined origin 
of  the tumor, axillary EBT carcinoma or axillary metastasis 
from unknown primary breast cancer, irradiation of  the 
homolateral breast should also be performed.5,10
EBT carcinoma prognosis is thought to be worse than 
in normal breast tissue, mainly because of  its rareness 
and difficulty in making an early diagnosis and also 
because metastasis to lymph nodes occur earlier and more 
commonly than in normal breast carcinoma.7,9,10
Learning Points/Take Home Messages
A subcutaneous nodule of  undetermined origin found at 
breast periphery should be evaluated very carefully.
Its evaluation should be performed similarly to breast 
examination, including physical exam, mammography and 
ultrasound.
In these situations, EBT carcinoma should always be 
excluded.
The early detection and treatment of  EBT carcinoma is 
essential for its good outcome.
Recebido / Received 13/03/2017
Aceite / Acceptance 25/05/2017
Divulgações Éticas / Ethical disclosures
Conflitos de interesse: Os autores declaram não possuir conflitos de interesse.
Conflicts of  interest: The authors have no conflicts of  interest to declare.
Suporte financeiro: O presente trabalho não foi suportado por nenhum 
subsídio ou bolsa. 
Financing Support: This work has not received any contribution, grant or 
scholarship.
Confidencialidade dos dados: Os autores declaram ter seguido os protocolos 
do seu centro de trabalho acerca da publicação dos dados de doentes.
Confidentiality of  data: The authors declare that they have followed the 
protocols of  their work center on the publication of  data from patients.
Protecção de pessoas e animais: Os autores declaram que os procedimentos 
seguidos estavam de acordo com os regulamentos estabelecidos pelos 
responsáveis da Comissão de Investigação Clínica e Ética e de acordo 
com a Declaração de Helsínquia da Associação Médica Mundial
Protection of  human and animal subjects: The authors declare that the 
procedures followed were in accordance with the regulations of  the 
relevant clinical research ethics committee and with those of  the Code 
of  Ethics of  the World Medical Association (Declaration of  Helsinki).
References
1. Francone E, Nathan MJ, Murelli F, Bruno MS, Traverso E, Friedman 
D. Ectopic breast cancer: case report and review of  the literature. Aesth 
Plast Surg. 2013;37:746–9. 
2. Kahraman-Cetintas S, Turan-Ozdemir S, Topal U. Carcinoma 
originating from aberrant breast tissue. A case report and review of  the 
literature. Tumori. 2008;94:440-3. 
3. Devine C, Courtney C-A, Deb R, Agrawal A. Invasive lobular carcinoma 
arising in accessory breast tissue. World Journal of  Surgical Oncology 
2013;11:47. 
4. DeFilippis EM, Arleo EK. The ABCs of  Accessory breast tissue: 
basic information every radiologist should know. American Journal of  
Roentgenology. 2014;202:1157–62. 
5. Soares A, Gonçalves J, Azevedo I, Pereira HG. Lobular ectopic breast 
carcinoma: A case-report. Reports of  Practical Oncology & Radiotherapy. 
2013;18:189–91. 
6. Teke Z, Kabay B, Akbulut M, Erdem E. Primary infiltrating ductal 
carcinoma arising in aberrant breast tissue of  the axilla: a rare entity. 
Report of  a case. Tumori. 2008;94:577-83.
7. Rho JY, Juhng SK, Yoon KJ. Carcinoma originating from aberrant 
breast tissue of  the right upper anterior chest wall. J Korean Med Sci. 
2001;16:519-21.
8. Visconti G, Eltahir Y, Van Ginkel RJ, Bart J, Werker PMN. Approach 
and management of  primary ectopic breast carcinoma in the axilla: Where 
are we? A comprehensive historical literature review. Journal of  Plastic, 
Reconstructive & Aesthetic Surgery. 2011;64:e1–e11. 
9. Dhebri A, Shah N, Sripadam R, Arora PK. Skin lesion in axilla: an 
unusual presentation of  invasive lobular carcinoma of  breast. BMJ Case 
Reports. 2012. 
10. Sun L-M, Meng F-Y, Chang N-J, Lu C-Y, Lu T-H, Liang J-A, et al. 
Primary infiltrating ductal carcinoma of  the axillary breast with metastasis 
to the contralateral chest wall. Journal of  the Chinese Medical Association. 
2013;76:354–7. 
